Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
1,326
-
Total 13F shares, excl. options
-
94,041,724
-
Shares change
-
+1,215,395
-
Total reported value, excl. options
-
$98,807,158,234
-
Value change
-
+$1,312,660,088
-
Put/Call ratio
-
143%
-
Number of buys
-
647
-
Number of sells
-
511
-
Price
-
$1051.03
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2024
As of 30 Jun 2024 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 1,326 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 94,041,724 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, STATE STREET CORP, Capital World Investors, Capital International Investors, GEODE CAPITAL MANAGEMENT, LLC, Dodge & Cox, and FRANKLIN RESOURCES INC.
This table shows 1,326 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.